IR2-10

Form of Awards - Lump Sum and Periodical Payments

Infected Blood Inquiry · Second Interim Report · Issued 5 April 2023 · Addressed to: UK Government

Government responseUK Government: Accepted (Dec 2024)

DeliveryNo statement from UK Government found

Recommendation, verbatim from the inquiry

●Inquiry recommendation

I recommend that: a) awards should be made in a lump sum in respect of an Injury Impact Award, Social Impact Award, Autonomy Award, and an award to compensate for past losses under the Care Award and Financial Loss Award for infected and affected persons; b) at the option of the applicant, for continuing future losses under the Care Award and Financial Loss Award, there should be paid either a lump sum award or payment by way of guaranteed periodical payments uplifted annually for inflation for life, or the predicted period of the loss, if earlier; c) an infected person should have the option of receiving a lesser lump sum as a provisional award (i.e. one assessed on the footing that as a result of receiving infected blood or blood products or tissue transfer there is a chance that at some definite or indefinite time in the future they will develop some serious disease or suffer some serious deterioration in their physical or mental health) such that in that case they may return to the scheme, or in accordance with arrangements to be made by the scheme, for further compensation then to be paid in respect of the newly developed disease or deterioration; and d) unless the option to have a provisional award is taken, all awards should be final.

Infected Blood Inquiry, Second Interim Report · 5 Apr 2023 Source PDF →

Published evidence summary

AI-generated evidence summary

The UK Government stated in December 2024 that acceptance of an award does not require applicants to waive their right to pursue litigation (Cabinet Office response, Dec 2024). It added that if an infected person's condition deteriorates, they will be able to return to IBCA at any time for reassessment to determine eligibility for an additional compensation payment, regardless of the time that has passed since their initial assessment (Cabinet Office response, Dec 2024). The record holds no update since the UK Government's response of December 2024 (Cabinet Office response, Dec 2024).

Sources

AI-generated summary of the record on this page, checked by a second model and automatic checks, 26 Sep 2026.

Government response

●UK Government · Accepted · 17 Dec 2024

Words of: The UK Government, in the Government response to the Infected Blood Inquiry (CP 1224), 17 December 2024

In line with recommendations 9 and 10 of the Second Interim Report, acceptance of an award does not require applicants to waive their right to pursue litigation. In defined circumstances, if an infected person's condition deteriorates after their compensation award has been assessed, they will be able to return to IBCA for reassessment to determine whether they are eligible for an additional compensation payment. A reassessment following a health deterioration will be possible at any time, regardless of the time that has passed since a person's initial assessment.

Extract from: Government response to the Infected Blood Inquiry

Delivery

No statement on delivery from UK Government has been found in the sources searched. This is separate from the response above.

How this page is built

The recommendation and the government responses are verbatim from primary documents. Delivery statements and other bodies' findings are shown in their own words, each with its source. The summary is written by this site and labelled as such. The Index does not paraphrase sources or characterise intent; it records what has been published.